Isoniazid Dosing for 6-Month (6H) Treatment Regimen
For latent tuberculosis infection (LTBI), the 6-month isoniazid monotherapy regimen is an alternative option: adults receive 5 mg/kg (typically 300 mg) daily, and children receive 10-15 mg/kg (maximum 300 mg) daily. 1
Dosing by Population
Adults
- Daily dosing: 5 mg/kg, typically 300 mg once daily 2
- Twice-weekly dosing: 15 mg/kg, typically 900 mg (not recommended for 6-month regimen) 2
- Maximum daily dose: 300 mg 3
Children
- Daily dosing: 10-15 mg/kg once daily, maximum 300 mg 2, 3
- Twice-weekly dosing: 20-30 mg/kg (not recommended for 6-month regimen) 2
- Doses should be rounded up to facilitate administration 4
Clinical Context and Recommendations
The 6-month isoniazid regimen (6H) is classified as an alternative regimen rather than preferred for LTBI treatment 1. It is:
- Strongly recommended for HIV-negative adults and children (moderate certainty evidence) 1
- Conditionally recommended for HIV-positive adults and children (moderate certainty evidence) 1
Preferred regimens have replaced 6H in most scenarios due to better completion rates and shorter duration, including 3 months of weekly isoniazid-rifapentine (3HP) or 4 months of daily rifampin 1. The 6H regimen has lower treatment completion rates and higher hepatotoxicity risk compared to rifamycin-based regimens, which decreases its overall effectiveness despite good efficacy 1.
Administration Guidelines
- Timing: Take 30-60 minutes before food or 2 hours after food 4
- Frequency: Daily administration is standard; 5-7 days per week is acceptable 2
- Duration: Complete 6 months (approximately 180 doses) 1
Pyridoxine (Vitamin B6) Supplementation
Pyridoxine 25-50 mg daily must be co-administered to all patients at risk of peripheral neuropathy 2, 4:
- Pregnant women and breastfeeding infants
- HIV-positive persons
- Patients with diabetes, alcoholism, malnutrition, or chronic renal failure
- Advanced age
- Children receiving the increased 10-15 mg/kg dosing 5
For patients who develop peripheral neuropathy, increase pyridoxine to 100 mg daily 2.
Important Caveats
The 6H regimen should only be used after active tuberculosis disease is definitively excluded through appropriate clinical, radiographic, and bacteriologic evaluation 3. Using isoniazid monotherapy when active TB is present risks developing drug resistance.
Weight-based dosing is critical in children: The WHO revised pediatric isoniazid dosing upward from 5 mg/kg to 10-15 mg/kg in 2010 to achieve adequate drug exposures 6, 5. Lower doses (5 mg/kg) previously used are no longer recommended despite older studies showing efficacy 7.
For low body weight adults (particularly relevant in Asian populations), consider the 5 mg/kg weight-based calculation rather than the fixed 300 mg dose to avoid excessive exposure and adverse effects 4, 8.
Monitoring Requirements
- Baseline liver function tests in all patients 4
- Monthly monitoring if underlying liver disease, alcohol abuse, or hepatitis B coinfection 4
- Clinical assessment for symptoms of hepatotoxicity (nausea, vomiting, abdominal pain, jaundice) 2
- Adherence monitoring can be performed using INH test strips that detect isoniazid metabolites in urine 4
The evidence strongly supports that while 6H is effective for LTBI, shorter rifamycin-based regimens should be prioritized when feasible due to superior completion rates and comparable or better safety profiles 1.